Sio Gene Therapies Financials
SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio |
Please note, the imprecision that can be found in Sio Gene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sio Gene Therapies. Check Sio Gene's Beneish M Score to see the likelihood of Sio Gene's management manipulating its earnings.
Sio Gene Stock Summary
Sio Gene competes with CytomX Therapeutics, Assembly Biosciences, Instil Bio, Nuvation Bio, and Rezolute. Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York. Sio Gene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US8293991043 |
Business Address | 130 West 42nd |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.siogtx.com |
Phone | 877 746 4891 |
Currency | USD - US Dollar |
Sio Gene Key Financial Ratios
Sio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sio Gene's current stock value. Our valuation model uses many indicators to compare Sio Gene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sio Gene competition to find correlations between indicators driving Sio Gene's intrinsic value. More Info.Sio Gene Therapies is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sio Gene's earnings, one of the primary drivers of an investment's value.Sio Gene Market Pulse
Quote | 0.4 |
Change(%) | 2.56 |
Change | 0.01 |
Open | 0.39 |
Low | 0.39 |
High | 0.42 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Sio Gene is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Sio has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Sio Gene's financials are consistent with your investment objective using the following steps:- Review Sio Gene's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Sio Gene's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Sio Gene's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Sio Gene's stock is overvalued or undervalued.
Sio Gene January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sio Gene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sio Gene Therapies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sio Gene Therapies based on widely used predictive technical indicators. In general, we focus on analyzing Sio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sio Gene's daily price indicators and compare them against related drivers.
Information Ratio | (0.09) | |||
Maximum Drawdown | 11.21 | |||
Value At Risk | (2.38) | |||
Potential Upside | 2.33 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |